Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 15.45 billion as of March 9, 2026. Its market cap has increased by 8.26% in one year.

Market Cap

15.45B

Enterprise Value

17.35B

Revenue

6.11B

Ranking

n/a

PE Ratio

19.50

Stock Price

30.80

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 15.45B, an increase of 2,547.11%. That is a compound annual growth rate of 17.95%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	15.92B	-2.01%
Dec 31, 2025	16.25B	12.06%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ScinoPharm Taiwan	17.12B
YungShin Global Holding	14.46B
Grape King Bio	17.85B
Foresee Pharmaceuticals	12.86B
Alar Pharmaceuticals	12.83B
Handa Pharmaceuticals	12.55B
TTY Biopharm Company	20.74B
Standard Chemical & Pharmaceutical	11.54B

Market Cap Rankings